Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Chugai's novel T cell-redirecting antibody targets both CD3 and glypican-3

May 20, 2016

Novel, dual IDO1/TDO inhibitor RG-70099 is active in vivo

May 19, 2016

Evestra describes first-in-class leukemia inhibitory factor inhibitor

May 19, 2016

New CDC7 inhibitor shows broad antitumor activity in vivo

May 18, 2016

GVK Biosciences reports development of selective PI3Kbeta inhibitors

May 18, 2016

Cancer immunotherapy uses T cells expressing inducible MyD88/CD40 and targeted T-cell receptors

May 18, 2016

ME-401 well tolerated in healthy subjects, study in patients planned

May 18, 2016

CDK9 inhibitor AZ-5576 is potent, selective and orally active

May 18, 2016

New pan-RAF and VEGFR-2 dual inhibitor blocks tumor growth in vivo

May 17, 2016

Antitumor immune responses seen with TNFSF18 fusion protein GITRL-Fc

May 17, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...